FILE:MDT/MDT-8K-20100427172945.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed in Medtronic's 2009 proxy statement filed on July 17, 2009, on April 16, 2009, the Compensation Committee (the "Committee") of the Board of Directors of Medtronic, Inc. (the "Company") approved a five percent reduction in the annual base salaries of the Company's executive officers, including named executive officers, effective April 25, 2009. On April 22, 2010, the Committee reinstated the annual base salaries of the Company's executive officers, including named executive officers, to the levels existing prior to the April 2009 reductions. The reinstatement is effective May 1, 2010. The following table shows the reduced and reinstated base salaries of the named executive officers:
 
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


